Every day, the sun rises on Wall Street, and a plethora of professional analysts wake to issue new opinions on stocks. Here at the Fool, we use our "This Just In" column to examine some of these picks -- and the track records of the firm behind them -- so individuals can make better investing decisions.
In addition to following professional firms, anyone can use Motley Fool CAPS to monitor the collective opinions of more than 130,000 members, some of whom demonstrate better investing insight than published analysts.
More top-performing CAPS members are having that bullish feeling about Immucor
As hospitals have tightened capital spending and delayed orders of major purchases, medical device makers such as Intuitive Surgical
In its most recent quarter, Immucor beat Wall Street's earnings expectations, with revenue growing 12%. The company also anticipates that fiscal 2009 profit will come in at the high end of, or slightly above, its previous guidance. Even though Immucor signed a five-year renewal agreement with Quest Diagnostics
To see what the very best CAPS analysts are saying now about Immucor -- as well as other winning stocks they are picking -- head on over to CAPS and have a look. The community research and resources in CAPS are totally free, unlike analyst opinions reserved for paying clients.
Always looking ahead, the Motley Fool Rule Breakers team has recommended stocks like Hansen Medical and Intuitive Surgical to soundly beat the market. To see what other rule-breaking stocks David Gardner is picking today, take a free 30-day trial.
Fool contributor Dave Mock recently upgraded his TV with some fancy rabbit ears -- bring on the digital TV! He doesn't own shares of any companies mentioned here. Hansen Medical and Intuitive Surgical are Rule Breakers recommendations. Quest Diagnostics is an Inside Value pick. Johnson & Johnson is an Income Investor selection. The Fool's disclosure policy was actually part of the Olympic basketball Dream Team -- you probably just never saw it sitting on the bench.